Galmed Pharmaceuticals Ltd (GLMD) Reaches $5.95 52-Week High, Atwood Oceanics (ATW) Sellers Decreased By 0.25% Their Shorts

June 14, 2017 - By Marie Mckinney

The stock of Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) hit a new 52-week high and has $6.25 target or 5.00% above today’s $5.95 share price. The 8 months bullish chart indicates low risk for the $75.65M company. The 1-year high was reported on Jun, 14 by Barchart.com. If the $6.25 price target is reached, the company will be worth $3.78 million more. The stock increased 15.53% or $0.8 on June 14, reaching $5.95. About 149,723 shares traded or 462.72% up from the average. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) has risen 0.41% since June 14, 2016 and is uptrending. It has underperformed by 16.29% the S&P500.

Atwood Oceanics Incorporated (NYSE:ATW) had a decrease of 0.25% in short interest. ATW’s SI was 21.80 million shares in June as released by FINRA. Its down 0.25% from 21.85 million shares previously. With 4.40 million avg volume, 5 days are for Atwood Oceanics Incorporated (NYSE:ATW)’s short sellers to cover ATW’s short positions. The SI to Atwood Oceanics Incorporated’s float is 28.73%. The stock decreased 5.37% or $0.53 on June 14, reaching $9.34. About 2.02M shares traded. Atwood Oceanics, Inc. (NYSE:ATW) has declined 21.05% since June 14, 2016 and is downtrending. It has underperformed by 37.75% the S&P500.

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. The company has market cap of $75.65 million. The Firm focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate , called aramchol. It currently has negative earnings. The Company’s product candidate, aramchol, is a disease modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis (NASH).

Among 2 analysts covering Galmed Pharmaceuticals Ltd (NASDAQ:GLMD), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Galmed Pharmaceuticals Ltd has $22 highest and $19 lowest target. $20.50’s average target is 244.54% above currents $5.95 stock price. Galmed Pharmaceuticals Ltd had 3 analyst reports since August 14, 2015 according to SRatingsIntel. The firm has “Buy” rating by Roth Capital given on Thursday, August 13. The company was reinitiated on Monday, March 28 by H.C. Wainwright.

Investors sentiment decreased to 1.05 in 2016 Q4. Its down 0.05, from 1.1 in 2016Q3. It is negative, as 35 investors sold Atwood Oceanics, Inc. shares while 57 reduced holdings. 39 funds opened positions while 58 raised stakes. 65.75 million shares or 3.36% less from 68.03 million shares in 2016Q3 were reported. Oak Assocs Limited Oh reported 34,245 shares. Art Advsrs Ltd Llc holds 0.08% or 99,100 shares. California State Teachers Retirement Systems invested 0% of its portfolio in Atwood Oceanics, Inc. (NYSE:ATW). Panagora Asset Management has invested 0.03% in Atwood Oceanics, Inc. (NYSE:ATW). The Minnesota-based Walleye Trading Limited Liability Corp has invested 0% in Atwood Oceanics, Inc. (NYSE:ATW). Parametric Portfolio Associate Limited Liability owns 520,429 shares for 0.01% of their portfolio. Meeder Asset Mngmt Inc reported 0.07% in Atwood Oceanics, Inc. (NYSE:ATW). Comerica Savings Bank invested 0.01% of its portfolio in Atwood Oceanics, Inc. (NYSE:ATW). Gotham Asset Management Ltd Liability has 0.12% invested in Atwood Oceanics, Inc. (NYSE:ATW) for 703,121 shares. Citadel Advisors Ltd Llc holds 0% in Atwood Oceanics, Inc. (NYSE:ATW) or 33,561 shares. Grp One Trading L P stated it has 0% of its portfolio in Atwood Oceanics, Inc. (NYSE:ATW). Nomura Asset Com Limited reported 0% in Atwood Oceanics, Inc. (NYSE:ATW). Lsv Asset holds 0% or 57,783 shares. Wellington Mgmt Gru Llp stated it has 0% of its portfolio in Atwood Oceanics, Inc. (NYSE:ATW). National Bank Of America De reported 144,856 shares.

Atwood Oceanics, Inc. is an offshore drilling firm engaged in the drilling and completion of exploration and development wells for the global gas and oil industry. The company has market cap of $774.82 million. The Firm owns various types of drilling rigs, such as Ultra-Deepwater Rigs, Deepwater Semisubmersibles and Jackups. It has a 6.77 P/E ratio. The Company’s Ultra-deepwater Rigs and Deepwater Semisubmersibles include Atwood Achiever, Atwood Archer, Atwood Admiral, Atwood Advantage, Atwood Condor, Atwood Eagle and Atwood Osprey.